| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-17 |
4 |
OE |
$6.90 |
$225,554 |
D/D |
32,689 |
1,076,351 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-17 |
4 |
AS |
$140.14 |
$4,582,866 |
D/D |
(32,689) |
1,043,662 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-21 |
4 |
OE |
$6.90 |
$908,065 |
D/D |
110,930 |
1,088,656 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-21 |
4 |
AS |
$139.79 |
$15,631,693 |
D/D |
(110,930) |
977,726 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-22 |
4 |
OE |
$10.29 |
$131,887 |
D/D |
12,817 |
990,543 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-22 |
4 |
AS |
$141.28 |
$1,812,397 |
D/D |
(12,817) |
977,726 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-29 |
4 |
S |
$133.72 |
$355,929 |
D/D |
(2,660) |
975,066 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-02-03 |
4 |
S |
$157.14 |
$458,849 |
D/D |
(2,920) |
972,146 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-02-04 |
4 |
S |
$153.63 |
$1,362,698 |
D/D |
(8,870) |
963,276 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,040 |
991,316 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-02-07 |
4 |
S |
$155.55 |
$718,672 |
D/D |
(4,620) |
986,696 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,100 |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-04-28 |
4 |
OE |
$10.29 |
$38,999 |
D/D |
3,790 |
1,036,121 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-04-28 |
4 |
AS |
$155.12 |
$587,905 |
D/D |
(3,790) |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-04-29 |
4 |
AS |
$155.31 |
$10,346,256 |
D/D |
(66,210) |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-04-29 |
4 |
OE |
$10.29 |
$681,301 |
D/D |
66,210 |
1,098,541 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-05-20 |
4 |
OE |
$10.29 |
$736,144 |
D/D |
70,000 |
1,102,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-05-20 |
4 |
AS |
$155.60 |
$10,917,528 |
D/D |
(70,000) |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-05-27 |
4 |
OE |
$11.92 |
$834,400 |
D/D |
70,000 |
1,102,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-05-27 |
4 |
AS |
$165.52 |
$11,631,349 |
D/D |
(70,000) |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-06-20 |
4 |
OE |
$11.92 |
$1,076,138 |
D/D |
90,280 |
1,122,611 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-06-20 |
4 |
AS |
$159.96 |
$14,770,187 |
D/D |
(90,280) |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-04 |
4 |
S |
$157.88 |
$812,293 |
D/D |
(5,145) |
1,027,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-12 |
4 |
AS |
$159.92 |
$12,885,910 |
D/D |
(80,458) |
1,027,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-12 |
4 |
OE |
$17.65 |
$1,420,084 |
D/D |
80,458 |
1,107,644 |
0 |
- |
|
283 Records found
|
|
Page 8 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
